Search results: Sage Journals

Restricted accessResearch articleFirst published September, 2008

Some Guidelines for Interim Data Review of Clinical Trial Data

Dennis W. King, Jeremy D. Jokinen

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published November, 2010

Interim Analysis: What Regulatory Affairs Professionals Need to Know

David Coutant

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 2002

A Database Quality Review Process with Interim Checks

Rocco Brunelle, Robert Kleyle

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published October, 2015

Data monitoring committees for pragmatic clinical trials

Susan S Ellenberg, Richard Culbertson, Daniel L Gillen [...]

Clinical Trials

Restricted accessOtherFirst published December, 2009

Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit

John M Lachin

Clinical Trials

Restricted accessResearch articleFirst published February, 2015

Protecting the confidentiality of interim data: Addressing current challenges

Thomas R Fleming

Clinical Trials

Restricted accessResearch articleFirst published December, 2022

Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial

Brett S Hanscom, Deborah J Donnell, Thomas R Fleming [...]

Clinical Trials

Restricted accessResearch articleFirst published August, 2018

How to construct an optimal interim report: What the data monitoring committee does and doesn’t need to know

James D Neaton, Birgit Grund, Deborah Wentworth

Clinical Trials

Restricted accessResearch articleFirst published November, 2001

Translating Evidence into Practice: Pursuing Perfection in Pneumococcal Vaccination in a Rural Community

Daniel M Doyle, Robin Dauterive, Kenneth H Chuang [...]

Respiratory Care

Restricted accessResearch articleFirst published September, 2008

Some Guidelines for Interim Data Review of Clinical Trial Data

Dennis W. King, Jeremy D. Jokinen

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published November, 2010

Interim Analysis: What Regulatory Affairs Professionals Need to Know

David Coutant

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published March, 2019

Developing,Planning and Conducting an Interim Analysis: Lessons From the DEVOTE Cardiovascular Outcomes Trial (Trial Comparing Cardiovascular Safety of Insulin Degludec Versus Insulin Glargine in Patients With Type 2 Diabetes at High Risk of Cardiovascular Events)

Hanne Theilgaard, Inger Mollerup, Ida Carøe Helmark [...]

Therapeutic Innovation & Regulatory Science

Restricted accessOtherFirst published April, 2002

A Database Quality Review Process with Interim Checks

Rocco Brunelle, Robert Kleyle

Therapeutic Innovation & Regulatory Science

Restricted accessResearch articleFirst published October, 2015

Data monitoring committees for pragmatic clinical trials

Susan S Ellenberg, Richard Culbertson, Daniel L Gillen [...]

Clinical Trials

Restricted accessOtherFirst published December, 2009

Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit

John M Lachin

Clinical Trials

Restricted accessResearch articleFirst published February, 2015

Protecting the confidentiality of interim data: Addressing current challenges

Thomas R Fleming

Clinical Trials

Restricted accessResearch articleFirst published December, 2022

Evaluating group-sequential non-inferiority clinical trials following interim stopping: The HIV Prevention Trials Network 083 trial

Brett S Hanscom, Deborah J Donnell, Thomas R Fleming [...]

Clinical Trials

Restricted accessResearch articleFirst published August, 2018

How to construct an optimal interim report: What the data monitoring committee does and doesn’t need to know

James D Neaton, Birgit Grund, Deborah Wentworth

Clinical Trials

Restricted accessResearch articleFirst published November, 2001

Translating Evidence into Practice: Pursuing Perfection in Pneumococcal Vaccination in a Rural Community

Daniel M Doyle, Robin Dauterive, Kenneth H Chuang [...]

Respiratory Care